Chile · Delayed Price · Currency is CLP · Price in USD Abbott Laboratories Statistics
Total Valuation
SNSE:ABT has a market cap or net worth of CLP 169.24 trillion. The enterprise value is 174.05 trillion.
| Market Cap | 169.24T |
| Enterprise Value | 174.05T |
Important Dates
The last earnings date was Thursday, January 22, 2026.
| Earnings Date | Jan 22, 2026 |
| Ex-Dividend Date | Jan 15, 2026 |
Share Statistics
| Current Share Class | 1.74B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.73B |
Valuation Ratios
The trailing PE ratio is 28.80 and the forward PE ratio is 19.65.
| PE Ratio | 28.80 |
| Forward PE | 19.65 |
| PS Ratio | 4.24 |
| PB Ratio | 3.67 |
| P/TBV Ratio | 8.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 29.62 |
| EV / Sales | 4.53 |
| EV / EBITDA | 17.47 |
| EV / EBIT | 23.92 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.13 |
| Debt / FCF | n/a |
| Interest Coverage | 45.37 |
Financial Efficiency
Return on equity (ROE) is 13.16% and return on invested capital (ROIC) is 11.45%.
| Return on Equity (ROE) | 13.16% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.45% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 350.26M |
| Profits Per Employee | 51.55M |
| Employee Count | 115,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SNSE:ABT has paid 1.75 trillion in taxes.
| Income Tax | 1.75T |
| Effective Tax Rate | 22.94% |
Stock Price Statistics
The stock price has increased by +11.59% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +11.59% |
| 50-Day Moving Average | 129.12 |
| 200-Day Moving Average | 121.72 |
| Relative Strength Index (RSI) | 1.41 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.07 |
Income Statement
In the last 12 months, SNSE:ABT had revenue of CLP 39.93 trillion and earned 5.88 trillion in profits. Earnings per share was 3,350.86.
| Revenue | 39.93T |
| Gross Profit | 22.65T |
| Operating Income | 7.56T |
| Pretax Income | 7.63T |
| Net Income | 5.88T |
| EBITDA | 10.35T |
| EBIT | 7.56T |
| Earnings Per Share (EPS) | 3,350.86 |
Balance Sheet
The company has 6.97 trillion in cash and 11.69 trillion in debt, with a net cash position of -4,721.84 billion.
| Cash & Cash Equivalents | 6.97T |
| Total Debt | 11.69T |
| Net Cash | -4,721.84B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 46.18T |
| Book Value Per Share | 26,395.18 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 56.71%, with operating and profit margins of 18.94% and 14.72%.
| Gross Margin | 56.71% |
| Operating Margin | 18.94% |
| Pretax Margin | 19.10% |
| Profit Margin | 14.72% |
| EBITDA Margin | 25.93% |
| EBIT Margin | 18.94% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2,261.63, which amounts to a dividend yield of 1,802.96%.
| Dividend Per Share | 2,261.63 |
| Dividend Yield | 1,802.96% |
| Dividend Growth (YoY) | 5.76% |
| Years of Dividend Growth | 8 |
| Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | 1,802.90% |
| Earnings Yield | 3.47% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |